The Oncology Drug Shortages and Its Impact on Community Hospitals

The ongoing shortage of oncology drugs, particularly generic chemotherapies like platinum agents, has had a disproportionate impact on community and safety net hospitals in the United States and globally. These institutions, often serving rural and underserved populations, face significant challenges due to limited financial resources. This article examines the practical implications of these shortages through the lens of a community hospital, where creative solutions were employed to maximize limited resources where drug shortages were concerned. This article also highlights the emergence of gray and black markets, raising concerns about drug quality, especially in low-income and middle-income countries. Broader market dynamics-including rising platinum prices and recent health care policy changes-threaten to deepen disparities in cancer care. Systemic reforms are required to improve supply chain resilience, ensure equitable drug access, and protect vulnerable institutions and populations from the consequences of ongoing and future drug shortages.